Announcement on Conversion Result of Convertible Bonds and Share Changes
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Filed with SSE · · 4 pages · Chinese
DaShenLin Pharmaceutical Group Co., Ltd. has announced the results of its convertible bonds conversion and the resulting changes in share capital. As of a specified date, a small portion of the convertible bonds has been converted into shares, with the majority remaining unconverted. The report details the issuance of the convertible bonds, their conversion dates, and the adjustments made to the conversion price due to various corporate actions. The total number of shares has increased slightly due to the conversion of bonds into shares during the reporting period.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Announcement on Conversion Result of Convertible Bonds and Share Changes
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
DaShenLin Pharmaceutical Group Co., Ltd. on 6ix
Follow DaShenLin Pharmaceutical into a list and get an email when it puts out news.
Follow DaShenLin Pharmaceutical